Want to take quizzes and track your credits?
Symptoms of vulvar and vaginal atrophy, such as dyspareunia, dryness, burning, and pruritus, affect more than 50% of midlife and older women.1 Previously, the term vulvovaginal atrophy (VVA) was used to refer to these symptoms. However, there is increasing recognition that the loss of estrogen resulting from the cessation of ovarian function may also promote urinary frequency and urgency, prompting a new broader term, genitourinary syndrome of menopause (GSM).1 GSM includes symptomatic VVA as well as lower urinary tract symptoms related to low estrogen levels. GSM symptoms adversely affect quality of life and cause pain during sex, loss of libido, avoidance of intimacy, urinary urgency, dysuria, and recurrent symptomatic urinary tract infections. If left unmanaged, GSM can be progressive and often debilitating, with severe symptoms and anatomic changes sometimes requiring pelvic floor physical therapy and vaginal dilator therapy. Many women who have GSM symptoms are undiagnosed and untreated, and women often do not identify GSM as the cause of their symptoms.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Carolyn J. Crandall, MD, MS, David Geffen School of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, 1100 Glendon Ave, Ste 850, Room 858, Los Angeles, CA 90024 (firstname.lastname@example.org).
Published Online: September 26, 2019. doi:10.1001/jama.2019.15100
Conflict of Interest Disclosures: None reported.
You currently have no searches saved.